Dynamic monitoring of serum ferritin as an adverse prognostic biomarker in patients with multiple myeloma

Conclusion: SF can be used as a prognostic factor at initial diagnosis and relapse in patients with MM.PMID:34651511 | DOI:10.2217/bmm-2020-0849

Source: Future Medicine: Biomarkers in Medicine - October 15, 2021 Category: Internal Medicine Authors: Yanqing Zhang Jiaqi Pan Xi Chen Lianjie Wang Liyan Chen Yaoyao Tian Wei Wang Source Type: research